Back to search

Article

Identification of DDIT4 as a Potential Prognostic Marker Associated with Chemotherapy and Immunotherapy Response in Triple-Negative Breast Cancer

2022-10-24

Abstract excerpt

<h4>Background: </h4> Triple-negative breast cancer (TNBC) is the most heterogenous and aggressive subtype of breast cancer. Chemotherapy remains the standard treatment option for patients with TNBC owing to the unavailability of acceptable targets and biomarkers in clinical practice. Novel biomarkers and targets for patient stratification and treatment of TNBC are urgently needed. In this study, we aimed to ident...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4287d822-2695-53b0-bf21-82b68c2f33ef
DOI
10.21203/rs.3.rs-2175810/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of DDIT4 as a Potential Prognostic Marker Associated with Chemotherapy and Immunotherapy Response in Triple-Negative Breast CancerDOI 10.21203/rs.3.rs-2175810/v1
Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancerSemantic proximity
Identification of a novel gene signature with DDR and EMT difunctionalities for predicting prognosis, immune activity, and drug response in breast cancerSemantic proximity
Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancerSemantic proximity
Secondary Transcriptomic Analysis of Triple Negative Breast Cancer Reveals Reliable Universal and Subtype-Specific BiomarkersSemantic proximity
An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancerSemantic proximity
A Retrospective View on Triple Negative Breast Cancer Microenvironment: Novel Markers, Interactions, and Mechanisms of Tumor-Associated Components using public Single-cell RNA Seq DatasetsSemantic proximity
Molecular subtyping and functional validation of TTK, TPX2, UBE2C, and LRP8 in sensitivity of TNBC to paclitaxelSemantic proximity
The effect of DDIT3 on luminal A type breast cancerSemantic proximity
Integrated analysis of expression profiling data identifies three genes in correlation with poor prognosis of triple-negative breast cancerSemantic proximity
A Novel Immune Checkpoint-Related Gene Signature to Predict Overall Survival and Immunotherapy Response in Triple-Negative Breast CancerSemantic proximity
New Biomarkers and Treatment Advances in Triple-Negative Breast CancerSemantic proximity
Integrated bioinformatics analysis reveals ISG15, IFIH1, OAS2, MX1, and CXCL10 as predictive biomarkers of neoadjuvant chemotherapy response in triple-negative breast cancerSemantic proximity
Select a neighboring publication to make it the new centre.